Clinical Trials Directory

Trials / Terminated

TerminatedNCT02702713

Pivotal Assessment of the Effects of Bioactive on Health and Wellbeing. From Human Genome to Food Industry

Investigation of the Effect of Daily Consumption of Bioactive Enriched Foods (BEF) on Biochemical and Anthropometric Markers of Metabolic Syndrome (MS)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
325 (actual)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This is a multi-centre, randomised, double-blind, placebo-controlled, parallel-arm dietary intervention study. In total, 800 men and women at risk for Metabolic Syndrome (MS) will be recruited. Subjects will be eligible to the study if they present with two to four of the MS diagnostic criteria, at least one of them being: * fasting triglycerides ≥150 mg/dL but ≤400 mg/dL OR * HDL-cholesterol ≤50 mg/mL in women, ≤ 40mg/mL in men (with fasting triglycerides ≥110 mg/dL). Each of the four recruiting centres will recruit 200 volunteers. Participants will be randomly assigned to one of four groups to receive either: * Dairy BEF + egg placebo + bakery placebo * Egg BEF + dairy placebo + bakery placebo * Bakery BEF + dairy placebo + egg placebo * Dairy, egg and bakery placebo Participants will be required to consume all three of the allocated products each day for 12 weeks. Eligible volunteers will be included and randomly allocated to one of the four groups. At baseline, 6 weeks and 12 weeks after inclusion, each participant will visit the recruiting centre for clinical and biochemical investigations. At 3 weeks and 9 weeks participants will complete questionnaires relating to their satisfaction with the food products, compliance to consumption of the study food products, and any gastrointestinal side effects or health-related adverse events that have occurred in the previous 3 weeks. At each recruiting centre 40 participants will be required to take part in additional activities, these are: stool sample collection, adipose tissue aspiration, body composition analysis by dual energy x-ray absorptiometry (DEXA) and assessment of physical activity.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDairy BEFDairy BEF: Milkshake powder enriched with 250 mg of DHA and 3g beta-glucans
DIETARY_SUPPLEMENTEgg BEFEgg BEF: Frozen pancakes enriched with 250 mg of DHA and 320 mg of anthocyanins
DIETARY_SUPPLEMENTBakery BEFBakery BEF: Biscuits enriched with 250 mg of DHA and 320 mg of anthocyanins
DIETARY_SUPPLEMENTBakery placeboBakery placebo: Biscuits without enrichment
DIETARY_SUPPLEMENTDairy placeboDairy placebo: Milkshake powder without enrichment
DIETARY_SUPPLEMENTEgg placeboEgg placebo: Frozen pancakes without enrichment

Timeline

Start date
2016-02-01
Primary completion
2017-10-20
Completion
2017-10-20
First posted
2016-03-09
Last updated
2017-12-02

Locations

4 sites across 4 countries: France, Germany, Italy, United Kingdom

Source: ClinicalTrials.gov record NCT02702713. Inclusion in this directory is not an endorsement.